Hypertension in Pregnancy
Hypertension in Pregnancy
Hypertension in Pregnancy
Induced
Hypertension
Jun Ma
Dept. of Obstetrics & Gynecology
The First Hospital of Xian Jiaotong Univ
Introduction
Hypertension in pregnancy
Definition
Diastolic BP 90 mmHg
Classification
Classification of Hypertensive
Disorders in Pregnancy (ACOG)
Pregnancy-induced hypertension
Preeclampsia
Mild
Severe
Eclampsia
Chronic hypertension preceding pregnancy
Chronic hypertension with superimposed PIH
Superimposed preeclampsia
Superimposed eclampsia
Gestational hypertension
Classification (1)
1.
Pregnancy-induced hypertension:
Hypertension associated with proteinuria and edema,
occurring primarily in nulliparas after the 20th week or
near term.
Preeclampsia
mild
BP 140/90mmHg
Epigastric discomfort
Thrombocytopenia
Classification (2)
severe
BP 160/110 mmHg
Classification (3)
Eclampsia
Classification (4)
2. Chronic hypertension proceeding
pregnancy (essential or secondary to
renal disease, endocrine disease, or
other causes)
BP 140/90 mmHg
Classification (5)
3. Chronic hypertension with superimposed
preeclampsia or eclamptia
Classification (6)
4.
Nulliparous
Chronic nephritis
Diabetic
Malnutrition
Hydatidiform mole
Etiology: UNCLEAR
Genetic factor
Insulin resistance
Pathophysiology
Eyes
Serous
retinal detachment
Cortical blindness
Pulmonary system
Pulmonary edema
Cardiogenic or noncardiogenic
Kidneys
Decreased GFR
Proteinuria
Liver
Subclinical involvement
Cardiovascular system
Capillary leak
Blood (1)
Volume: reduced plasma volume
Normal physiologic volume expansion
does not occur
Generalized vasoconstriction and capillary
leak
Hematocrit
DIC (5%)
1.
2.
3.
4.
5.
Endocrine system
Disequilibrium of prostacyclin/
thromboxane A2
Placenta perfusion
500 mm vs 200 mm
IUGR or stillbirth
Degree of edema
Eclamptic seizures
Pulmonary edema
Abruptio placenta
Renal failure
Differential diagnosis
Complications
Preterm delivery
IUGR
Oligohydramnios
Prevention
Treatment
A.
B. Severe preeclampsia:
Magnesium sulfate
1. Decreases the amount of
acetylcholine released at the
neuromuscular junction
2. Blocks calcium entry into neurons
3. Vasodilates the smaller-diameter
intracranial vessels
Magnesium sulfate
1. Prevent convulsion
2. Virtually ineffective on blood pressure
3. i.v. or i.m.
5g loading dose 5-10 min, i.v.
1-2g/hr constant infusion
Total dose: 20-30 g/d
Toxicity:
Diminished or loss of patellar reflex
Diminished respiration
Muscle paralysis
Blurred speech
Cardiac arrest
Reversal of toxicity:
Antihypertensive therapy:
reduce the Dia. pressure to 90-110 mmHg
Indication
Antihypertensive therapy
Medications:
Labetolol
Nifedipine
Nimoldipine
Methyldoe
Sodium nitroprusside
Mechanism
of action
Effects
hydralazine
Direct peripheral
vasodilation
labetalol
a, b- adrenergic
blocker
Medication
nifedipine
Calcium channel
blocker
methyldopa
Direct peripheral
CO, RBF maternal flushing,
arteriolar vasodilation headache, tachycardia
sodium nitroprusside
Direct peripheral
vasodilation
Metabolite (cyanide)
toxic to fetus
Plasma expander
Diuretics
Delivery
function
3. 2 hs after control of seizure
Delivery
Induction of labor
1.
2.
3.
Cesarean section
1.
2.
3.
Eclampsia
Unconsciousness
Management
Control of seizure
Control of hypertension
Delivery
Proper nursing care